No Data
Express News | Corrected-Cumberland Pharmaceuticals Inc: Evaluating Options for Caldolor Payment (Removes Extraneous Word 'cms')
Express News | Cumberland Pharmaceuticals Inc: CMS Excludes Caldolor From Nopain Act Separate Payment List
Cumberland Pharmaceuticals (CPIX.US) will release its financial report after the market closes on November 7th.
Cumberland Pharmaceuticals (CPIX.US) will release its earnings report after the market closes on November 7th. How was its previous performance? For 2024 Q2, revenue was $9.848849 million, net income was -$-1.102637 million, and eps was -$0.08. For 2023 Q3, revenue was $10.085926 million, net income was -$-1.063219 million, and eps was -$0.07. The above data is presented in accordance with US GAAP. Futubull reminder: 1. Hong Kong stocks, US
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
Earnings Call Summary | Cumberland Pharmaceuticals(CPIX.US) Q2 2024 Earnings Conference
Cumberland Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
No Data
No Data
Ultratech : there's that and ceo also just bought 25k in shares
Sean Parker OP Ultratech : I posted this months ago. which one are you talking about lol?
Ultratech Sean Parker OP : grwg was on 8/28
Sean Parker OP Ultratech : I just looked and yes he did before the weekend. I'll keep that in mind. good looking out.
Ultratech Sean Parker OP : booyah